News Room
Stay up-to-date with the latest news from Repligen, including company announcements, product launches, industry insights, and upcoming events. Explore how we’re advancing innovation in bioprocessing and shaping the future of therapeutic manufacturing.
News
February 14, 2020
Repligen up on OPUS® and Gene Therapy Demand
Dan Stanton BioProcess International
News
October 1, 2019
Using Alternating Tangential Flow with Fed-Batch Cultures
GEN
News
August 12, 2019
Samsung BioLogics implants cell-culturing tech
Korea Biomed
News
August 12, 2019
Samsung BioLogics Implements Large Scale N-1 Perfusion for Commercial Application
Yahoo News
News
August 12, 2019
Samsung BioLogics’ cell culture technique to cut production life by 30%
Pulse News
News
August 12, 2019
Samsung BioLogics Implements Large Scale N-1 Perfusion for Commercial Application.
Samsung Biologics
News
May 20, 2019
OPUS focus: Repligen expands to support chromatography demand
Dan Stanton BioProcess International
News
August 21, 2018
Fortune Top 100 Fastest-Growing Companies in 2018
Fortune Inc.
News
November 1, 2017
Purolite Selects Repligen's Market-Leading OPUS® Pre-Packed Columns
PR Newswire
News
October 3, 2017
Balancing the up and downstream: Repligen CEO talks R&D and M&A
Dan Stanton BioPharma Reporter
News
June 23, 2017
Repligen agrees to buy Spectrum for $359 milion
Robert Weisman Boston Globe
News
March 8, 2017
Repligen to up column production on back of 'milestone year of chromatography'
Dan Stanton BioPharma Reporter